Other languages Immatics N.V.

Equities

IMTX

NL0015285941

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-01 EDT			5-day change	1st Jan Change
10.81 ^USD	+8.86%		+6.50%	+2.66%

04-17	Certain Ordinary Shares of Immatics N.V. are subject to a Lock-Up Agreement Ending on 17-APR-2024.	CI
04-17	Certain Warrants of Immatics N.V. are subject to a Lock-Up Agreement Ending on 17-APR-2024.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Gain Pre-Bell Thursday	03-21
Sector Update: Health Care	03-21
Immatics Swings to 2023 Net Loss, Revenue Falls -- Shares Down Pre-Bell	03-21
Immatics N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	03-21
Sector Update: Health Care Stocks Mixed Premarket Thursday	01-18
Immatics Prices $175 Million Share Offering	01-18
Immatics Plans Common Stock Offering	01-17
Immatics N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14
Immatics N.V. Reports Interim Clinical Data from ACTengine IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRame in an Ongoing Phase 1 Trial	11-08
Immatics' IMA203 TCR-T Program Receives Regenerative Medicine Advanced Therapy Designation	23-10-24
Immatics N.V. Receives FDA Regenerative Medicine Advanced Therapy Designation for ACTengine(R) IMA203 TCR-T Monotherapy	23-10-24
Aktien New York Schluss: Weitere Gewinne nach jüngstem Rücksetzer	23-09-11
Aktien New York: Weitere Gewinne nach jüngstem Rücksetzer	23-09-11
Moderna se asocia con Immatics para impulsar el desarrollo de vacunas contra el cáncer	23-09-11
Moderna : collaboration stratégique avec Immatics	23-09-11
Moderna und Immatics schmieden Milliardendeal für Krebsmedikamente	23-09-11
Moderna, Immatics to Collaborate to Develop Novel Cancer Therapies	23-09-11
Moderna intensifica sus esfuerzos contra el cáncer con una nueva asociación -- Market Talk	23-09-11
Moderna, Immatics to work jointly on cancer vaccines	23-09-11
Moderna, Immatics to collaborate for cancer vaccines	23-09-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Immatics N.V.

Equities

IMTX

NL0015285941

Other languages

Filters